screen_shot_2012-08-21_at_09

INC Research promotes Jamie Macdonald to chief executive

pharmafile | August 21, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing INC Research, Jamie Macdonald 

Clinical research organisation INC Research has announced chief operating officer Jamie Macdonald will become the firm’s next president and chief executive.

Chairman and chief executive James Ogle will continue to serve as chairman of the company. Promoted to the role of COO is Alistair Macdonald, president, Clinical Development Services, who brings nearly 20 years of experience in the CRO industry to his new position, including 10 years with INC Research.

Ogle, Jamie Macdonald and Alistair Macdonald will assume their new roles 1 January 2013.

Advertisement

Ogle recently completed his ninth year as chief executive of INC Research and has served as a member of the company’s board of directors since 2003.  He has spent 25 years in the CRO and biopharmaceutical industries, following a military career during which he achieved the rank of lieutenant colonel in the US Army.

“On behalf of the board of directors, we would like to take this opportunity to recognise Jim Ogle’s tremendous contributions to INC Research,” said David Burgstahler, president and partner, Avista Capital Partners and INC Research Board member.

Chief executive Ogle added: “A results-driven leader, Jamie Macdonald brings to the chief executive position proven CRO industry operational and financial leadership experience, exceptional strategic insight and a relentless drive to achieve service excellence for our customers. We have every confidence in his ability to navigate INC Research through the next phase of our growth as we expand our leadership position.”

Jamie Macdonald added: “I look forward to working closely with Jim to ensure a smooth transition and with our global leadership team to execute on our strategic plans to drive long-term exceptional value for our customers and shareholders.”

Related Content

syneos_health_rgb_tm

INC Research and inVentiv merge to form Syneos Health

With the advent of the new year, INC Research and inVentiv Health have announced they …

Contract research news in brief

TFS buys Italian CRO Dimensione Ricerca, AMRI closes a US facility plus business development updates …

Contract research news in brief

A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, …

The Gateway to Local Adoption Series

Latest content